ReviewJournal of magnetic resonance imaging : JMRI2025
Current Landscape of Short-T2 Imaging Techniques in the Musculoskeletal System: The Past, Present and Future.
Review in Journal of magnetic resonance imaging : JMRI, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Deep learning-based chemical shift-artifact correction of ZTE MRI for enhanced bone depiction of the lumbar spine.Skeletal radiology · 2026Article
- Concurrent AI assistance with LI-RADS classification for contrast enhanced MRI of focal hepatic nodules: a multi-reader, multi-case study.Abdominal radiology (New York) · 2026Article
- Comparative evaluation of MRI-based bone-targeted sequences and computed tomography for preoperative assessment of midfacial trauma.Scientific reports · 2026Article
- Giant cell tumor of the orbital roof: A case report and brief review of literature.Radiology case reports · 2026Article
- Current Uses for Medical Imaging With Orthopaedic Implant Technology.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2026Review
- Comparison of FRACTURE MRI, Conventional Radiography, and CT in the Evaluation of Bone Tumors.Radiology. Imaging cancer · 2026Article
- Current Landscape of Short-T2 Imaging Techniques in the Musculoskeletal System: The Past, Present and Future.Journal of magnetic resonance imaging : JMRI · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Conventional MRI is limited in imaging tissues with short T2 relaxation times, such as bone, ligaments, and cartilage, due to their rapid signal decay. This limitation has spurred the development of specialized MRI techniques designed specifically for short-T2 tissue imaging. Traditional pulse sequences, including three-dimensional gradient echo (3D-GRE), susceptibility-weighted imaging (SWI), and Fast Field Echo Resembling a CT using Restricted Echo-Spacing (FRACTURE), initially addressed some of these challenges but often lacked sufficient resolution or contrast differentiation. Recent advancements, such as ultrashort echo time (UTE), zero echo time (ZTE), 3D-Bone, and synthetic computed tomography (sCT), have significantly enhanced the diagnostic capabilities of MRI by providing high-quality, CT-like visualization without exposure to ionizing radiation. These innovations have substantially improved MRI's ability to depict bone morphology, assess joint pathology, identify subtle fractures, and characterize bone tumors with higher accuracy. Beyond musculoskeletal applications, these techniques have demonstrated emerging clinical utility in additional domains, including pulmonary and dental imaging. This review article evaluates conventional pulse sequences alongside emerging MRI innovations, highlighting their clinical applications, current limitations, and technical considerations. Continued optimization of these techniques promises broader clinical adoption, potentially reducing dependence on invasive and radiation-intensive imaging modalities. Evidence Level: N/A Technical Efficacy: Stage 3.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.